-The Times of India CHENNAI: The Centre's recent decision to disclose information related to public-private partnerships (PPP) to RTI applicants may throw a spanner in the works of several infrastructure projects. While RTI activists have hailed the move saying it would usher in greater accountability, private players are cold to the idea as they apprehend the use of RTI to create opposition to projects. Industrial sources said most private firms are not...
More »SEARCH RESULT
Total Matching Records found : 840
Drilling holes in the Thirst Economy-P Sainath
-The Hindu As the borewells go deeper in Maharashtra, there have been worrying instances of ‘paleo-historic storages' being breached "Only two of them work," says Badri Kharat of his borewells in Roshangaon. That's hard - when you've sunk 36 of them spending millions of rupees, as he has. Kharat, a big landowner and local political personage, has been generous to his neighbours in this village of Jalna district. He pipes in drinking...
More »Social Justice
KEY TRENDS • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8 • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...
More »Drought fuels big business on wheels-Jaideep Hardikar
-The Telegraph JALNA AND AHMEDNAGAR: Sakharam Misal is frank. Water, he says, is big business. In Jalna district, which has run out of water, the man in his late 50s is among the most sought after. He runs a water tanker business and sells water to the thirsty millions. Misal's cellphone keeps ringing with desperate calls for water. His tankers are booked in advance and the waiting list stretches over a week. Drought,...
More »SC’s Novartis judgement renews focus on accessible medicine
The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...
More »
